Professor Michael Belkin, Head of NurExone Biologic’s Ophthalmology Project, will receive the Lifeti...

RetinalGenix Technologies Inc. has successfully begun patient imaging using the first prototype of i...

Perceive Pharma has announced the closing of a $15 million Series A funding round, supported by lead...

Opus Genetics has completed enrollment in the VEGA-3 Phase 3 clinical trial evaluating phentolamine ...

Luxa Biotechnology LLC has announced that the U.S. Food and Drug Administration (FDA) has granted Re...

Alcon has officially launched Systane PRO Preservative-Free (PF) in the United States, expanding its...

Telomir Pharmaceuticals has released results from its recent preclinical studies conducted in human ...

Heart Eye Diagnostics Limited, a UK-based company, has announced the launch of Dr.Noon CVD, an advan...

Opus Genetics has reached a significant milestone in its ongoing Phase 1/2 clinical trial for OPGx-L...

Seonix Bio has launched SightScore in the United States, marking the first commercially available cl...